Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Coriolis Pharma
Sort By
Newest First
1 / 1
1 / 1
Particle ID
Leveraging Formulation Development Experience for Effective Particle Identification
Jörg Müller, Ph.D.
Coriolis Pharma
PAO-10-24-CL-10
Nov 18, 2024
Commercialization
Development Strategies for Overcoming Commercialization Challenges
Matthias Lucke, Ph.D.
Coriolis Pharma
PAO-09-24-CL-10
Sep 17, 2024
IND Enablement
IND Enablement and Drug Product Development – Mitigating Risk and Accelerating through the "Valley of Death"
Johannes Clemens
Coriolis Pharma
PAO-08-24-CL-07
Aug 16, 2024
CRDO
Partnering with Scientific Excellence to De-Risk and Accelerate Drug Development
Silvia Steyrer-Gruber
Coriolis Pharma
PAO-07-24-CL-05
Jul 16, 2024
Monoclonal Antibodies
Coriolis Pharma Launches U.S. Entity Alongside Innovative Drug Product Platform Service Offerings for Monoclonal Antibodies
Coriolis Pharma
PR-05-24-NI-02
Jun 18, 2024
